APA (7th ed.) Citation

L, L., X, L., C, G., M, L., M, P., & L, W. (2025). Hsa-miR-21 promoted the progression of lung adenocarcinoma by regulating LRIG1 expression. BMC pulmonary medicine, 25(1), 189. https://doi.org/10.1186/s12890-025-03620-1

Chicago Style (17th ed.) Citation

L, Liu, Liu X, Gao C, Liu M, Peng M, and Wang L. "Hsa-miR-21 Promoted the Progression of Lung Adenocarcinoma by Regulating LRIG1 Expression." BMC Pulmonary Medicine 25, no. 1 (2025): 189. https://doi.org/10.1186/s12890-025-03620-1.

MLA (9th ed.) Citation

L, Liu, et al. "Hsa-miR-21 Promoted the Progression of Lung Adenocarcinoma by Regulating LRIG1 Expression." BMC Pulmonary Medicine, vol. 25, no. 1, 2025, p. 189, https://doi.org/10.1186/s12890-025-03620-1.